1. Home
  2. TIL vs EB Comparison

TIL vs EB Comparison

Compare TIL & EB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • EB
  • Stock Information
  • Founded
  • TIL 2018
  • EB 2003
  • Country
  • TIL United States
  • EB United States
  • Employees
  • TIL N/A
  • EB N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • EB EDP Services
  • Sector
  • TIL Health Care
  • EB Technology
  • Exchange
  • TIL Nasdaq
  • EB Nasdaq
  • Market Cap
  • TIL 171.7M
  • EB 202.5M
  • IPO Year
  • TIL 2021
  • EB 2018
  • Fundamental
  • Price
  • TIL $13.23
  • EB $2.49
  • Analyst Decision
  • TIL Buy
  • EB Hold
  • Analyst Count
  • TIL 5
  • EB 5
  • Target Price
  • TIL $114.00
  • EB $5.25
  • AVG Volume (30 Days)
  • TIL 180.4K
  • EB 730.4K
  • Earning Date
  • TIL 05-20-2025
  • EB 05-08-2025
  • Dividend Yield
  • TIL N/A
  • EB N/A
  • EPS Growth
  • TIL N/A
  • EB N/A
  • EPS
  • TIL N/A
  • EB N/A
  • Revenue
  • TIL N/A
  • EB $312,649,000.00
  • Revenue This Year
  • TIL N/A
  • EB N/A
  • Revenue Next Year
  • TIL N/A
  • EB $11.32
  • P/E Ratio
  • TIL N/A
  • EB N/A
  • Revenue Growth
  • TIL N/A
  • EB N/A
  • 52 Week Low
  • TIL $9.62
  • EB $1.81
  • 52 Week High
  • TIL $92.00
  • EB $5.92
  • Technical
  • Relative Strength Index (RSI)
  • TIL 44.22
  • EB 66.49
  • Support Level
  • TIL $11.97
  • EB $2.05
  • Resistance Level
  • TIL $14.67
  • EB $2.20
  • Average True Range (ATR)
  • TIL 2.05
  • EB 0.12
  • MACD
  • TIL -0.04
  • EB 0.04
  • Stochastic Oscillator
  • TIL 17.87
  • EB 63.31

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

Share on Social Networks: